Precigen Files Proxy Statement for July 5th Annual Meeting

Ticker: PGEN · Form: DEF 14A · Filed: May 28, 2024 · CIK: 1356090

Precigen, Inc. DEF 14A Filing Summary
FieldDetail
CompanyPrecigen, Inc. (PGEN)
Form TypeDEF 14A
Filed DateMay 28, 2024
Risk Levellow
Pages16
Reading Time19 min
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, annual-meeting, corporate-governance

TL;DR

Precigen's proxy is out for the July 5th meeting - vote on directors & auditors.

AI Summary

Precigen, Inc. filed its definitive proxy statement (DEF 14A) on May 28, 2024, for its annual meeting of stockholders scheduled for July 5, 2024. The filing outlines the proposals to be voted on by shareholders, including the election of directors and the ratification of PricewaterhouseCoopers LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2024. Precigen, Inc. is a biopharmaceutical company formerly known as Intrexon Corp.

Why It Matters

This filing provides shareholders with crucial information to make informed decisions on corporate governance and company direction at the upcoming annual meeting.

Risk Assessment

Risk Level: low — This is a routine proxy filing detailing upcoming shareholder votes and is not indicative of immediate financial risk.

Key Players & Entities

  • Precigen, Inc. (company) — Registrant
  • July 5, 2024 (date) — Annual Meeting Date
  • May 28, 2024 (date) — Filing Date
  • PricewaterhouseCoopers LLP (company) — Independent Auditor
  • Intrexon Corp (company) — Former Company Name

FAQ

What is the primary purpose of this DEF 14A filing?

The primary purpose is to provide shareholders with information regarding the annual meeting of stockholders, including proposals to be voted upon, such as the election of directors and the ratification of the independent registered public accounting firm.

When is Precigen, Inc.'s annual meeting of stockholders scheduled to take place?

The annual meeting of stockholders is scheduled for July 5, 2024.

Who is Precigen, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2024?

PricewaterhouseCoopers LLP is proposed to be ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2024.

What was Precigen, Inc.'s former company name?

Precigen, Inc.'s former company name was Intrexon Corp.

On what date was this definitive proxy statement filed with the SEC?

This definitive proxy statement was filed with the SEC on May 28, 2024.

Filing Stats: 4,793 words · 19 min read · ~16 pages · Grade level 12 · Accepted 2024-05-28 16:44:39

Filing Documents

From the Filing

tm243011-1_nonfiling - none - 11.6050507s TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 Precigen, Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than The Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. TABLE OF CONTENTS PRECIGEN, INC. 20374 Seneca Meadows Parkway Germantown, Maryland 20876 NOTICE OF 2024 ANNUAL MEETING OF SHAREHOLDERS To Be Held On July 5, 2024 To Our Shareholders: You are cordially invited to attend the 2024 Annual Meeting of Shareholders (the "Annual Meeting") of Precigen, Inc. ("Precigen," "we," "us," "our," or the "Company") to be held in virtual meeting format only at 9:00 a.m. Eastern Time, Friday, July 5, 2024, for the following purposes: 1. to elect the nine nominees named in the accompanying Proxy Statement to the Board of Directors, each to serve a one-year term expiring at the earlier of the next Annual Meeting or until his or her successor is duly elected and qualified; 2. to ratify the appointment by the Audit Committee of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; 3. to approve a non-binding advisory resolution approving the compensation of the named executive officers; 4. to approve an amendment to the Precigen, Inc. 2023 Omnibus Incentive Plan to increase the number of shares of common stock which may be subject to awards thereunder by 2 million; and 5. to transact any other business that may properly be brought before the Annual Meeting or any adjournments or postponements thereof. To join the meeting webcast, go to www.VirtualShareholderMeeting.com/PGEN2024 shortly before the meeting time and follow the instructions. As of the date of this notice, we have not received notice of any matters, other than those set forth above, that may properly be presented at the Annual Meeting. If any other matters are properly presented for consideration at the meeting, the persons named as proxies on the proxy card, or their duly constituted substitutes, will be deemed authorized to receive notice on behalf of and to vote the shares represented by proxy or otherwise act on those matters in accordance with their business judgment. The Board of Directors has fixed the close of business on May 3, 2024 as the record date for determining those shareholders entitled to notice of and to vote at the Annual Meeting. We are furnishing our proxy materials and Annual Report on Form 10-K for the year ended December 31, 2023 (the "2023 Annual Report") by mail to our shareholders. Your vote is very important to us . Please read the Proxy Statement and then, regardless of whether you are able to attend the Annual Meeting, vote your shares as promptly as possible. Please note that in the absence of specific instructions as to how to vote, brokers may not vote your shares on the election of directors, the non-binding proposal to approve the compensation of the named executive officers or the proposal to approve an amendment to the Precigen, Inc. 2023 Omnibus Incentive Plan. You may revoke your proxy and change your vote by entering new instructions on either the telephone or internet voting system before 11:59 p.m. Eastern Time on July 4, 2024, by submitting a proxy with a later date before the polls close at the Annual Meeting, by delivering a written revocation to our Corporate Secretary such that it is received before the polls close at the Annual Meeting, or by voting your shares at the Annual Meeting. Please note that voting in advance in any of the ways described will not prevent you from attending the Annual Meeting should you choose to do so. Whether or not you attend the Annual Meeting, please vote your shares as promptly as possible. TABLE OF CONTENTS By Order of the Board of Directors, DONALD P. LEHR Corporate Secretary Germantown, Maryland May 28, 2024 IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON July 5, 2024 Our Proxy Statement and our 2023 Annual Report are available online, free of charge, at https://materials.proxyvote.com. TABLE OF CONTENTS TABLE OF CONTENTS Page QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING 1 CORPORATE GOVERNANCE 7 General 7

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.